Ing Groep Nv Intercept Pharmaceuticals, Inc. Transaction History

Ing Groep Nv

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$58.69 - $80.46 $296,384 - $406,322	-5,050 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$77.77 - $120.68 $392,738 - $609,434	5,050 New	5,050 $402,000
Q3 2018 Nov 06, 2018	SELL	$88.49 - $127.55 $2.43 Million - $3.51 Million	-27,500 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$60.0 - $85.67 $1.65 Million - $2.36 Million	27,500 New	27,500 $2.31 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.